BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26380554)

  • 1. Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines.
    Nowotarski SL; Feith DJ; Shantz LM
    Cancer Growth Metastasis; 2015; 8(Suppl 1):17-27. PubMed ID: 26380554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signaling cascades involved in nonmelanoma skin carcinogenesis.
    Feehan RP; Shantz LM
    Biochem J; 2016 Oct; 473(19):2973-94. PubMed ID: 27679857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
    Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
    Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamines and nonmelanoma skin cancer.
    Gilmour SK
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):249-56. PubMed ID: 17234230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches.
    An KP; Athar M; Tang X; Katiyar SK; Russo J; Beech J; Aszterbaum M; Kopelovich L; Epstein EH; Mukhtar H; Bickers DR
    Photochem Photobiol; 2002 Jul; 76(1):73-80. PubMed ID: 12126310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of nonmelanoma skin cancer incidence rates in kidney transplant recipients in Ireland.
    Bannon FJ; McCaughan JA; Traynor C; O'Brien K; Gavin AT; Maxwell AP; Comber H; Conlon PJ
    Transplantation; 2014 Sep; 98(6):646-52. PubMed ID: 24798309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periocular Skin Cancer in Solid Organ Transplant Recipients.
    Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
    Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).
    Martin J; Duncan FJ; Keiser T; Shin S; Kusewitt DF; Oberyszyn T; Satoskar AR; VanBuskirk AM
    FASEB J; 2009 Mar; 23(3):720-30. PubMed ID: 18952710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients.
    Bernat-García J; Morales Suárez-Varela M; Vilata-Corell JJ; Marquina-Vila A; Pallardo L; Crespo J
    Actas Dermosifiliogr; 2014 Dec; 105(10):940-6. PubMed ID: 25062648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations.
    Almahroos M; Kurban AK
    Skinmed; 2004; 3(1):29-35; quiz 35-6. PubMed ID: 14724410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism.
    Feith DJ
    Methods Mol Biol; 2011; 720():129-41. PubMed ID: 21318870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer of the head and neck region in solid organ transplant recipients.
    Ritter A; Bachar G; Feinmesser R; Shpitzer T; Popovtzer A; Rabinovics N
    Head Neck; 2019 Feb; 41(2):374-380. PubMed ID: 30549347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunburn and sun-protective behaviors among adults with and without previous nonmelanoma skin cancer (NMSC): A population-based study.
    Fischer AH; Wang TS; Yenokyan G; Kang S; Chien AL
    J Am Acad Dermatol; 2016 Aug; 75(2):371-379.e5. PubMed ID: 27198078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
    Veness MJ; Harris D
    Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.